<DOC>
	<DOCNO>NCT00151788</DOCNO>
	<brief_summary>The effect pactimibe versus placebo progression atherosclerosis carotid artery assess use standard ultrasound technique .</brief_summary>
	<brief_title>Efficacy Safety ACAT Inhibitor CS-505 ( Pactimibe ) Reducing Progression Carotid Artery Disease . This Study Also Known CAPTIVATE .</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>Confirmed diagnosis heterozygous familial hypercholesterolemia Ambulatory male ( 40 75 year , inclusive ) female ( 45 75 year , inclusive ) subject Calculated LDLC level great equal 100 mg/dL ( 2.5 mmol/L ) triglycerides less 500 mg/dL ( 5.65 mmol/L ) usual stable lipidlowering therapy Breast feeding lactate woman Previous organ transplantation Highgrade stenosis ( &gt; 75 % ) occlusion segment either carotid artery History carotid endarterectomy , insertion carotid artery stent schedule either procedure</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>